EHMT2 and head and neck squamous cell carcinoma: G9a can maintain CSC characteristics in head and neck squamous cell carcinoma [23]; therefore, we investigated whether G9a is generated as the downstream protein of EGFR in EGFR-positive lung tumor cells, for determining the stemness property in EGFR-positive lung cancer.